360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Pharmaceutical Research and Manufacturers of America

Image source: Freebase

Type: Organization

Name: Pharmaceutical Research and Manufacturers of America

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Frank Pallone

House panel approves drug-tracking bill

A House panel on Wednesday advanced legislation along party lines to increase the tracking of prescription drugs.The Safeguarding America's Pharmaceuticals Act of 2013 requires the Food and Drug Administration (FDA) to propose new rules to keep consumers ... [Published The Hill - May 15 2013]

Entities: Frank Pallone, FDA Food & Drug Administration, Janet Woodcock, Jan Schakowsky

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Northrop Grumman Corporation

Lobbyists spending down this year, Northrop Grumman leads the way for defense sector

Some of Washington's biggest spenders are spending less than they use to.An analysis by the Center for Responsive Politics shows lobbyist spending dropped in the first quarter of 2013. The exceptions were those groups involved in some hot-button issues, ... [Published al.com - May 14 2013]

Entities: Northrop Grumman Corporation, United Technologies Corporation, Military Expenditure

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Pharmaceutical Research and Manufacturers of America

PhRMA: Medicare Part D Unparalleled Success

PhRMA Statement on Medicare Part D and ProPublicaWASHINGTON, D.C. (May 12, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett today issued the following statement:“Medicare Part D is an unparalleled ... [Published Pharma Live - May 13 2013]

Entities: Medicare, Matthew Bennett, Pharmaceutical Research and Manufacturers of Am..., ProPublica, Health Care

First reported May 12 2013 - Updated May 12 2013 - 1 reports

People in the News (5/12/13): Appointments and Promotions

The William and Flora Hewlett Foundation has announced the appointment of HEATH WICKLINE and JOHN JETER as communications officers. Wickline, who most recently ran his own consulting firm, earlier worked as a senior account manager at Underground Advertising ... [Published The Foundation Center - May 12 2013]

Entities: Appointed, William E. Simon, Edythe Broad

First reported May 10 2013 - Updated May 10 2013 - 1 reports

National Association of Chain Drug Stores

NACDS joins initiative to improve medication adherence

The National Association of Chain Drug Stores (NACDS) has joined forces with other healthcare industry leaders to raise awareness of the need for better medication adherence and to advance public policy with near-term solutions.As a member of “Prescriptions ... [Published Drugtopics.com - May 10 2013]

Entities: National Association of Chain Drug Stores, National Consumers League, Pharmaceutical Research and Manufacturers of Am..., American Academy of Family Physicians, Easter Seals

First reported May 10 2013 - Updated May 10 2013 - 1 reports

JDRF appoints David E. Wheadon as executive vice president of research and advocacy

Juvenile Diabetes Research Foundation (JDRF), a global organization funding type 1 diabetes (T1D) research, has appointed David E. Wheadon, M.D., as its new executive vice president of research and advocacy.Wheadon brings 26 years of experience in drug ... [Published Center Watch - May 10 2013]

Entities: Appointed, Regulatory Affairs, Leadership

First reported May 08 2013 - Updated May 08 2013 - 1 reports

REUTERS SUMMIT-Drugmakers split as demands for open data mount

(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13)* Growing demands for transparency of clinical trial data* Wider disclosure by EU regulator angers drugmakers* GlaxoSmithKline sets up online system for data ... [Published London South East - May 08 2013]

Entities: European Medicines Agency, Clinical trials, Drugs

First reported May 08 2013 - Updated May 08 2013 - 1 reports

JDRF Welcomes David E. Wheadon, M.D. as New Executive Vice President of Research and Advocacy

"After conducting an international search for candidates to fill this important new role for JDRF, we found a perfect match in Dr. Wheadon's distinguished medical and research background, his deep knowledge of the regulatory process, and his demonstrated ... [Published Street Insider - May 08 2013]

Entities: Diabetes Type I, Leadership, Pharmaceutical Research and Manufacturers of Am..., Harvard College

First reported May 03 2013 - Updated May 03 2013 - 2 reports

PhRMA, Merck, Others Partner on Drug Adherence

Forbes | Pharmaceutical Research and Manufacturers of America (PhRMA), the National Association of Chain Drug Stores, the Council for Affordable Health Coverage, and the American Academy of Family Physicians have launched Prescriptions for a Healthy America ... [Published eCliniqua - May 03 2013]

Entities: Drugs, National Association of Chain Drug Stores, Pharmaceutical Research and Manufacturers of Am...

First reported May 01 2013 - Updated May 01 2013 - 1 reports

PhRMA Statement on Decision of the European General Court on. . .

PhRMA Statement on Decision of the European General Court on EMA Disclosure of Company DataTargeted News ServiceWASHINGTON, April 30 -- The Pharmaceutical Research and Manufacturers of America issued the following news release:Pharmaceutical Research ... [Published Equities.com - May 01 2013]

Entities: Pharmaceutical Research and Manufacturers of Am..., Clinical trials, Matt Bennett, Public Health

First reported Apr 30 2013 - Updated May 01 2013 - 2 reports

Drugmakers Get Reprieve in Medicare Cost-Cutting Panel Inaction

May 1 (Bloomberg) -- Pfizer Inc. and other drugmakers will avoid a reduction in U.S. government payments that was to be imposed in 2015 by a cost-cutting panel created by President Barack Obama’s Affordable Care Act.Spending in Medicare, the federal health ... [Published Washington Post - May 01 2013]

Entities: Medicare, Actuary, Affordable Care Act

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Hugin to lead PhRMA

Celgene’s Chairman and CEO Robert Hugin has been appointed chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). ... [Published Pharma Field - Apr 23 2013]

Entities: Pharmaceutical Research and Manufacturers of Am..., Celgene Corporation, Appointed

Quotes

...and with federal health care programs," said Maria Harris Tildon, CareFirst's Senior Vice President of Public Policy and Community Affairs. "We will rely on John's advocacy expertise and his understanding and knowledge of federal and state health care regulations as we embrace changes related to the Affordable Care Act."

CareFirst Names John Michael O'Brien Vice President of Public Policy [Published Citybizlist - May 13 2013]

"However, in light of the recent HIPAA Omnibus Rule effective this September that places new restrictions on the usage of protected health information, we have decided to end supplier-funded refill reminders through our retail business" DeAngelis said in an email

HIPAA Could Prompt Pharmacies to End Sponsored-refill Reminders [Published Medicexchange.com - May 10 2013]

Mr. Brewer continued: "Dr. Wheadon's broad exposure to industry, government, the Food and Drug Administration, academia, and influential policy and decision makersâalong with his world-class research training and credentialsâcover all the aspects of the translational research pipeline where JDRF works today. Under his leadership, we look forward to expanding JDRF's capabilities and increasing our emphasis on exciting translational opportunities that hold the most promise to improve the lives of people with type 1 diabetes in the next decade, on our way to a future where this disease is spoken about in the past tense." JDRF is the leading global organization funding type 1 diabetes (T1D) research...

JDRF Welcomes David E. Wheadon, M.D. as New Executive Vice President of Research and Advocacy [Published Street Insider - May 08 2013]

"We see more value from transparency and openness than not" GSK CEO Andrew Witty told Reuters last week. "I guess not everybody necessarily shares that view."

REUTERS SUMMIT-Drugmakers split as demands for open data mount [Published London South East - May 08 2013]

More Content

sort by: Date \| Relevance
House panel approves drug-tracking bill [Published The Hill - May 15 2013]
Lobbyists spending down this year, Northrop Gru... [Published al.com - May 14 2013]
Anteing Up for RFID [Published Pharmaceutical & Medical Packaging News - May 14 2013]
CareFirst Names John Michael O'Brien Vice Presi... [Published Citybizlist - May 13 2013]
PhRMA: Medicare Part D Unparalleled Success [Published Pharma Live - May 13 2013]
Delaware BioScience Association Celebrates Life... [Published BioMedReports - May 13 2013]
Bringing trial data out of the shadows [Published PMLive - May 13 2013]
Bringing trial data out of the shadows [Published PharmaGossip - May 13 2013]
People in the News (5/12/13): Appointments and ... [Published The Foundation Center - May 12 2013]
NACDS joins initiative to improve medication ad... [Published Drugtopics.com - May 10 2013]
Anna Protopapas replaces Deborah Dunsire as Mil... [Published FierceBiotech - May 10 2013]
JDRF appoints David E. Wheadon as executive vic... [Published Center Watch - May 10 2013]
HIPAA Could Prompt Pharmacies to End Sponsored-... [Published Medicexchange.com - May 10 2013]
John Castellani of PhRMA Appointed to Pharmacis... [Published Pharma-Mag - May 10 2013]
The great pill debate - A new bill proposes tha... [Published Santa Maria Sun - May 09 2013]
JDRF Welcomes David E. Wheadon, M.D. as New Exe... [Published Street Insider - May 08 2013]
REUTERS SUMMIT-Drugmakers split as demands for ... [Published London South East - May 08 2013]
ObamaCare Developments Could Have Major Impact ... [Published National Center for Public Policy Research - May 08 2013]
India shows US path to patent standards [Published Bangladesh Daily Star - May 08 2013]
World needs high patent standards [Published Business Daily Africa - May 07 2013]
India shows U.S. path to patent standards [Published Reuters - May 06 2013]
PhRMA Dismayed by Global IPR Report [Published Pharmaceutical Executive - May 06 2013]
PhRMA, Merck, Others Partner on Drug Adherence [Published eCliniqua - May 03 2013]
Merck, CVS Caremark, PhRMA And Others Band Toge... [Published Forbes.com - May 03 2013]
PhRMA "dismay" over US India, Canada trade moves [Published Pharma Times - May 03 2013]
New coalition makes medication adherence its mi... [Published Chain Drug Review - May 02 2013]
SEIA Hires Capitol Hill Veteran, Former PhRMA S... [Published Southeastgreen.com - May 02 2013]
Bar Coding and RFID on Track This Summer [Published Pharmaceutical & Medical Packaging News - May 01 2013]
Court blocks EMA release of pharma company data [Published PMLive - May 01 2013]
AT&T, Amway and lobbyists among donors to Bush ... [Published The Hill - May 01 2013]

Blogs

sort by: Date \| Relevance
Bringing trial data out of the shadows [Published PharmaGossip - May 13 2013] All sectors have their own mood music, unobtrusive much of the time, but occasionally brought to startling effect into the foreground, dominating all else. The pharmaceutical industry is no different, and at present there is one insistent theme: transparency. ...
John Castellani of PhRMA Appointed to Pharmacis... [Published Pharma-Mag - May 10 2013] John Castellani, President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), has been appointed to the advisory board of Pharmacist Partners, LLC. The announcement was made by Pharmacist Partners, the Clinical ...
After Myriad Oral Argument, Supreme Court Set t... [Published Biotech Blog - Apr 18 2013] Copyright © thinkBiotech This is a guest post by Morrison & Foerster ‘s Marc A. Hearron, James J. Mullen, III and Matthew I. Kreeger. Do you have a response to this post? Sound off in the comments section below. The Supreme Court of the United ...
Health groups say Medicare letter misrepresente... [Published PharmaGossip - Apr 03 2013] Allies of the pharmaceutical industry appear to have misrepresented the views of certain advocacy groups by listing them as supporters of a big lobbying push that they actually oppose.Some liberal healthcare advocates are charging the drug industry with ...
Novartis Ruling In India Could Spark Larger Mov... [Published Firedoglake - Apr 02 2013] Gleevec So let’s say you are a leading multinational pharmaceutical company and you have a blockbuster cancer drug. You patent the drug, make tremendous profits, but now the clock is ticking and the patent is set to expire. What do you do? If you ...

Audio/Video

sort by: Date \| Relevance
Fireside Chat With Robert Hugin, Chairman and C... [Published BIO Channel - YouTube - Feb 27 2013]
Robert Hugin, Chairman and Chief Executive Offi... [Published BIO Channel - YouTube - Feb 26 2013]
Fireside Chat With Robert Hugin, Chairman and C... [Published BIO Channel - YouTube - Feb 19 2013]
Ethics? Obamacare Architect Lobbies For Big Pharma [Published The Young Turks - YouTube - Dec 09 2012]

Press Releases

sort by: Date \| Relevance
Celgene's Robert J. Hugin Becomes PhRMA Board C... [Published PR Newswire: General Business - Apr 12 2013]
PhRMA Statement on Proposed Changes to Medicaid... [Published PR Newswire - Sep 12 2012]